AXL and neoplasm: AXL has emerged as a therapeutic drug target for TNBC treatment, and AXL-CAR-T cell therapy led to significant in vitro cytotoxicity and cytokine secretion as well as a reduction in tumor growth in an TNBC xenograft mouse model (98).